Dose-dependent effect of sitagliptin on carotid atherosclerosis in patients with type 2 diabetes mellitus receiving insulin treatment: A post hoc analysis
Diabetes Therapy Sep 26, 2017
Mita T, et al. - This analysis strived to examine the dose-dependent effect of sitagliptin on carotid atherosclerosis in patients with type 2 diabetes mellitus (T2DM) receiving insulin treatment. In a dose-dependent manner, the addition of sitagliptin to insulin therapy could attenuate the progression of atherosclerosis among patients with T2DM.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
